Invited commentary: The etiology of lung cancer in men compared with women

American Journal of Epidemiology

Volumn 177, Issue 7, 2013, Pages 613-616

  Alberg, Anthony J ^a   Wallace, Kristin ^b   Silvestri, Gerard A ^b   Brock, Malcolm V ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b NONE

Author keywords

cigarettes; estrogen; lung cancer; men; secondhand smoke exposure; sex; smoking; women

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; ESTROGEN; PROTEIN TYROSINE KINASE INHIBITOR; RADON;

CANCER; EPIDEMIOLOGY; ETIOLOGY; MENS HEALTH; SMOKING; TOBACCO; WESTERN WORLD; WOMENS HEALTH;

AIR POLLUTION; CANCER GROWTH; CANCER INCIDENCE; CANCER PROGNOSIS; CANCER RISK; CANCER SUSCEPTIBILITY; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; FEMALE; FOOD INTAKE; FRUIT; GENE MUTATION; HUMAN; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG CARCINOGENESIS; MALE; OCCUPATIONAL EXPOSURE; PASSIVE SMOKING; PHYSICAL ACTIVITY; RADIATION EXPOSURE; RECEPTOR GENE; REVIEW; SEX DIFFERENCE; SMOKING; TREATMENT RESPONSE; VEGETABLE;

FEMALE; HUMANS; LUNG NEOPLASMS; MALE; SMOKING;

UNITED STATES;

NICOTIANA TABACUM;

EID: 84875975951     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kws444     Document Type: Review

References (32)

1. Peto R, Lopez AD, Boreham J, et al. Mortality From Smoking in Developed Countries 1950-2000: Indirect Estimates From National Vital Statistics. New York, NY: Oxford University Press; 1994.
2. Office of the Surgeon General, US Public Health Service. The Health Effects of Active Smoking: A Report of the Surgeon General. Washington, DC: US Public Health Service; 2004.
3. Alberg AJ, Samet JM. Epidemiology of lung cancer. Chest. 2003;123(1 suppl):21S-49S.
4. Kohler BA, Ward E, McCarthy BJ, et al. Annual report to the nation on the status of cancer, 1975-2007, featuring tumors of the brain and other nervous system. J Natl Cancer Inst. 2011;103(9):714-736.
5. De Matteis S, Consonni D, Pesatori AC, et al. Are women who smoke at higher risk for lung cancer than men who smoke? Am J Epidemiol. 2013;177(7):601-612.
6. National Cancer Institute. Cigars: Health Effects and Trends. (Smoking and Tobacco Control monograph no. 9). Bethesda, MD: National Cancer Institute; 1998. (NIH publication no. 98-4302).
7. Office of the Surgeon General, US Public Health Service. The Health Consequences of Involuntary Exposure to Tobacco Smoke: A Report of the Surgeon General. Washington, DC: US Public Health Service; 2006.
8. International Agency for Research on Cancer. A Review of Human Carcinogens: Arsenic, Metals, Fibres, and Dusts. (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol 100C). Lyon, France: International Agency for Research on Cancer; 2012.
9. National Research Council, Committee on Health Risks of Exposure to Radon. Health Effects of Exposure to Radon (BEIR VI). Washington, DC: National Academy Press, 1999
10. Hosgood HD 3rd, Boffetta P, Greenland S, et al. In-home coal and wood use and lung cancer risk: a pooled analysis of the International Lung Cancer Consortium. Environ Health Perspect. 2010;118(12):1743-1747.
11. Turner MC, Krewski D, Pope CA 3rd, et al. Long-term ambient fine particulate matter air pollution and lung cancer in a large cohort of never-smokers. Am J Respir Crit Care Med. 2011;184(12):1374-1381.
12. Saracci R. The interactions of tobacco smoking and other agents in cancer etiology. Epidemiol Rev. 1987;9(1):175-193.
13. World Cancer Research Fund International. Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective. Washington, DC: World Cancer Research Fund/American Institute for Cancer Research; 2007.
14. Nelson DE, Davis RM, Chrismon JH, et al. Pipe smoking in the United States, 1965-1991: prevalence and attributable mortality. Prev Med. 1996;25(2):91-99.
15. Centers for Disease Control and Prevention. State-specific prevalence of current cigarette and cigar smoking among adults-United States, 1998. MMWR Morb Mortal Wkly Rep. 1999;48(45):1034-1039.
16. Olsson AC, Gustavsson P, Zaridze D, et al. Lung cancer risk attributable to occupational exposures in a multicenter casecontrol study in Central and Eastern Europe. J Occup Environ Med. 2011;53(11):1262-1267.
17. Centers for Disease Control and Prevention. Vital signs: nonsmokers? exposure to secondhand smoke-United States, 1999-2008. MMWR Morb Mortal Wkly Rep. 2010;59(35): 1141-1146.
18. Sisti J, Boffetta P. What proportion of lung cancer in neversmokers can be attributed to known risk factors? Int J Cancer. 2012;131(2):265-275.
19. Centers for Disease Control and Prevention. Prevalence of fruit and vegetable consumption and physical activity by race/ethnicity-United States, 2005. MMWR Morb Mortal Wkly Rep. 2007;56(13):301-304.
20. Wakelee HA, Chang ET, Gomez SL, et al. Lung cancer incidence in never smokers. J Clin Oncol. 2007;25(5):472-478.
21. Thun MJ, Hannan LM, Adams-Campbell LL, et al. Lung cancer occurrence in never-smokers: an analysis of 13 cohorts and 22 cancer registry studies. PLoS Med. 2008;5(9):e185.
22. Siegfried JM. Women and lung cancer: does oestrogen play a role? Lancet Oncol. 2001;2(8):506-513.
23. Siegfried JM, Hershberger PA, Stabile LP. Estrogen receptor signaling in lung cancer. Semin Oncol. 2009;36(6):524-531.
24. Greiser CM, Greiser EM, Doren M. Menopausal hormone therapy and risk of lung cancer-systematic review and metaanalysis. Maturitas. 2010;65(3):198-204.
25. Chlebowski RT, Anderson GL, Manson JE, et al. Lung cancer among postmenopausal women treated with estrogen alone in the Women?s Health Initiative randomized trial. J Natl Cancer Inst. 2010;102(18):1413-1421.
26. Slatore CG, Chien JW, Au DH, et al. Lung cancer and hormone replacement therapy: association in the Vitamins and Lifestyle Study. J Clin Oncol. 2010;28(9):1540-1546.
27. Siegfried JM. Early changes in pulmonary gene expression following tobacco exposure shed light on the role of estrogen metabolism in lung carcinogenesis. Cancer Prev Res. 2010; 3(6):692-695.
28. Levin ER. Bidirectional signaling between the estrogen receptor and the epidermal growth factor receptor. Mol Endocrinol. 2003;17(3):309-317.
29. Siegfried JM, Gubish CT, Rothstein ME, et al. Combining the multitargeted tyrosine kinase inhibitor vandetanib with the antiestrogen fulvestrant enhances its antitumor effect in non-small cell lung cancer. J Thorac Oncol. 2012;7(3): 485-495.
30. Shen H, Yuan Y, Sun J, et al. Combined tamoxifen and gefitinib in non-small cell lung cancer shows antiproliferative effects. Biomed Pharmacother. 2010;64(2):88-92.
31. Ren J-H, He W-S, Yan G-L, et al. EGFR mutations in non-small-cell lung cancer among smokers and non-smokers: a meta-analysis. Environ Mol Mutagen. 2012;53(1):78-82.
32. Kawaguchi T, Ando M, Kubo A, et al. Long exposure of environmental tobacco smoke associated with activating EGFR mutations in never-smokers with non-small cell lung cancer. Clin Cancer Res. 2011;17(1):39-45.